SCHEMBL18182154

SCHEMBL18182154

CCc1ccc(OCc2c(I)cccc2OC(=O)OC)c(CC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
LMNA P02545 2/20 0.36
RAB9A P51151 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
AKT1 P31749 1/20 0.36
SLC2A1 P11166 1/20 0.35
MTNR1A P48039 7/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MTNR1B P49286 6/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156095 0.90 PPARA (0.41) MAPTLMNARAB9AL3MBTL1SLC22A12
SCHEMBL18156250 0.90 ALOX15 (0.40) MAPTLMNAL3MBTL1SMN1; SMN2KMT2A
SCHEMBL18182756 0.90 MAPT (0.38) MAPTLMNARAB9AL3MBTL1SMN1; SMN2
SCHEMBL18182911 0.89 CYP1A2 (0.43) MAPTRAB9ASMN1; SMN2KMT2AHPGD
SCHEMBL18156096 0.89 MRGPRX4 (0.41) MAPTRAB9ASMN1; SMN2KMT2AHTT
SCHEMBL18182738 0.89 LMNA (0.42) LMNARAB9ASMN1; SMN2KMT2AHTT
SCHEMBL18178079 0.89 KDM4E (0.40) MAPTRAB9AL3MBTL1SMN1; SMN2KMT2A
SCHEMBL18182827 0.88 SMN1; SMN2 (0.42) MAPTLMNARAB9AL3MBTL1SMN1; SMN2
SCHEMBL18156189 0.87 L3MBTL1 (0.44) MAPTLMNARAB9AL3MBTL1SMN1; SMN2
SCHEMBL18182757 0.87 KDM4E (0.40) MAPTLMNARAB9AL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MAPT 4572/4885LMNA 4171/4885RAB9A 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.